Intermountain Forms Value-Based Care Company
A new comprehensive health platform company will focus on elevating value-based care capabilities with providers, payers, healthcare systems, and ACOs.
Rajesh Shrestha,
Intermountain Healthcare is forming a new value-based care company.
Called Castell, the company will offer a comprehensive platform of tools and services to support practice transformation and improvement. These resources will help all parts of the health ecosystem promote wellness for patients and excel within a value-based healthcare world.
“Intermountain has actively developed tools and initiatives to help providers and others successfully implement value-based care for years,” says Rajesh Shrestha, president and CEO of Castell. “Castell is one part of that work that we’re excited to officially share now."
Related article: Intermountain Healthcare, deCODE Launch Largest DNA Mapping Project in United States
The new company will offer a comprehensive platform of tools and services to support transformation and improvement:
- A proven value-based clinical care model called “Reimagined Primary Care”
- A technology and analytics platform to guide care
- Streamlined affiliated network management
- Digital tools to address virtual care, patient experience, and social determinants of health
- Access to cutting-edge initiatives and innovation coming out of Intermountain Healthcare
- Opportunity to utilize care pathways and clinical best practices developed by Intermountain Healthcare
“We continually see that without the right level of support, it is difficult for providers, health systems, payers, and others to thrive in a value-based healthcare world,” Shrestha says. “Intermountain’s day-to-day frontline experience and success in value-based care management programs make us uniquely prepared to extend our services to others through Castell. We are energized by this opportunity to simplify value-based care and help set the direction for the healthcare of the future.”
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More
Medicare Costs Rise in 2025 With Higher Part D Premiums, Advantage Deductibles
March 27th 2025During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new Medicare plans for the 2025 calendar year due to changes including the plans being offered, increases in premiums and more, according to an eHealth analysis.
Read More
